ETIG Analysis: Pharma companies involved in rolling out Covid-19 treatments face ESG implications

Moody's Investor Services said in a report last week that the ongoing Covid-19 vaccine development globally comes with both positives as well as negatives for pharma companies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gV8Iva
via IFTTT